Jonesy
@jonespharmd.bsky.social
•Husband
•Father
•Veteran
•Clinical Pharmacist specializing in pain management and harm reduction.
Lover of all things fantasy and science fiction. Been some places, seen some things, done some things.
My views are my own.
he/him/his
•Father
•Veteran
•Clinical Pharmacist specializing in pain management and harm reduction.
Lover of all things fantasy and science fiction. Been some places, seen some things, done some things.
My views are my own.
he/him/his
Just preordered @shaunalawless.bsky.social new book Daughter of the Otherworld! Can't wait to read it. @thebrokenbinding.bsky.social Thank you for sending out an opportunity to continue my signed and numbered collection! Super excited!
August 13, 2025 at 12:38 PM
Just preordered @shaunalawless.bsky.social new book Daughter of the Otherworld! Can't wait to read it. @thebrokenbinding.bsky.social Thank you for sending out an opportunity to continue my signed and numbered collection! Super excited!
Reposted by Jonesy
There’s some truth here.
April 9, 2025 at 4:01 PM
There’s some truth here.
The message was heard by so many people, yet lost on so many more. Layer after layer after layer, the performance was dope as hell. If this performance upset you, you're the problem. Kendrick was 🔥🔥🔥
February 10, 2025 at 1:01 PM
The message was heard by so many people, yet lost on so many more. Layer after layer after layer, the performance was dope as hell. If this performance upset you, you're the problem. Kendrick was 🔥🔥🔥
Reposted by Jonesy
Please share/rt boost. But right now, The Doors of Midnight hardcovers are 50 PERCENT off on a special sale. That's right, it's even cheaper than the paperback which is up for pre order and also sale.
www.barnesandnoble.com/w/the-doors-...
www.barnesandnoble.com/w/the-doors-...
February 5, 2025 at 4:24 PM
Please share/rt boost. But right now, The Doors of Midnight hardcovers are 50 PERCENT off on a special sale. That's right, it's even cheaper than the paperback which is up for pre order and also sale.
www.barnesandnoble.com/w/the-doors-...
www.barnesandnoble.com/w/the-doors-...
Food for thought: Imagine how the story would have changed if Moiraine let Agelmar kill Padan Fain in Fal Dara.
What single event within the main story (exclude historical events) would have had as significant an impact?
#WoTWednesday #TheWheelOfTime
What single event within the main story (exclude historical events) would have had as significant an impact?
#WoTWednesday #TheWheelOfTime
February 5, 2025 at 3:52 PM
Food for thought: Imagine how the story would have changed if Moiraine let Agelmar kill Padan Fain in Fal Dara.
What single event within the main story (exclude historical events) would have had as significant an impact?
#WoTWednesday #TheWheelOfTime
What single event within the main story (exclude historical events) would have had as significant an impact?
#WoTWednesday #TheWheelOfTime
Reposted by Jonesy
New: The largest medical A.I. randomized controlled trial yet performed, enrolling >100,000 women undergoing mammography screening
The use of AI led to 29% higher detection of cancer, no increase of false positives, and reduced workload compared with radiologists w/o AI thelancet.com/journals/lan...
The use of AI led to 29% higher detection of cancer, no increase of false positives, and reduced workload compared with radiologists w/o AI thelancet.com/journals/lan...
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, ...
The findings suggest that AI contributes to the early detection of clinically relevant
breast cancer and reduces screen-reading workload without increasing false positives.
thelancet.com
February 4, 2025 at 3:00 AM
New: The largest medical A.I. randomized controlled trial yet performed, enrolling >100,000 women undergoing mammography screening
The use of AI led to 29% higher detection of cancer, no increase of false positives, and reduced workload compared with radiologists w/o AI thelancet.com/journals/lan...
The use of AI led to 29% higher detection of cancer, no increase of false positives, and reduced workload compared with radiologists w/o AI thelancet.com/journals/lan...
Reposted by Jonesy
🚨MEDICATION RECALL🚨
Alvogen has recalled fentanyl patches bc of a manufacturing error that resulted in several patches getting stuck together and packaged as a single dose. This poses an overdose risk.
Bc of the current administration’s choices, FDA is unable to share this with the public.
Alvogen has recalled fentanyl patches bc of a manufacturing error that resulted in several patches getting stuck together and packaged as a single dose. This poses an overdose risk.
Bc of the current administration’s choices, FDA is unable to share this with the public.
February 2, 2025 at 4:04 PM
🚨MEDICATION RECALL🚨
Alvogen has recalled fentanyl patches bc of a manufacturing error that resulted in several patches getting stuck together and packaged as a single dose. This poses an overdose risk.
Bc of the current administration’s choices, FDA is unable to share this with the public.
Alvogen has recalled fentanyl patches bc of a manufacturing error that resulted in several patches getting stuck together and packaged as a single dose. This poses an overdose risk.
Bc of the current administration’s choices, FDA is unable to share this with the public.
Not likely a game changer given the clinical trial data (at least for now), but I feel suzetrigine will be another tool in the box to use for my pain management patients. It's only approved for acute pain, but there are ongoing neuropathic pain trials in play. Hopefully the data will be better.
FDA approves first new type of pain medication in 25 years | CNN
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
www.cnn.com
January 31, 2025 at 1:26 PM
Not likely a game changer given the clinical trial data (at least for now), but I feel suzetrigine will be another tool in the box to use for my pain management patients. It's only approved for acute pain, but there are ongoing neuropathic pain trials in play. Hopefully the data will be better.